Erythrodermic psoriasis and human immunodeficiency virus: association and therapeutic challenges*
Read
7706
Timeswas read the article
3031
Total PDF
4675
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 10 | 248 | 112 | 360 |
| 2025 9 | 217 | 66 | 283 |
| 2025 8 | 146 | 70 | 216 |
| 2025 7 | 161 | 70 | 231 |
| 2025 6 | 167 | 59 | 226 |
| 2025 5 | 186 | 66 | 252 |
| 2025 4 | 165 | 43 | 208 |
| 2025 3 | 199 | 30 | 229 |
| 2025 2 | 201 | 73 | 274 |
| 2025 1 | 163 | 52 | 215 |
| 2024 12 | 116 | 39 | 155 |
| 2024 11 | 127 | 48 | 175 |
| 2024 10 | 100 | 57 | 157 |
| 2024 9 | 142 | 76 | 218 |
| 2024 8 | 140 | 109 | 249 |
| 2024 7 | 139 | 105 | 244 |
| 2024 6 | 100 | 68 | 168 |
| 2024 5 | 92 | 77 | 169 |
| 2024 4 | 92 | 69 | 161 |
| 2024 3 | 74 | 60 | 134 |
| 2024 2 | 109 | 72 | 181 |
| 2024 1 | 78 | 42 | 120 |
| 2023 12 | 62 | 60 | 122 |
| 2023 11 | 71 | 59 | 130 |
| 2023 10 | 68 | 52 | 120 |
| 2023 9 | 59 | 47 | 106 |
| 2023 8 | 67 | 36 | 103 |
| 2023 7 | 73 | 29 | 102 |
| 2023 6 | 75 | 30 | 105 |
| 2023 5 | 72 | 21 | 93 |
| 2023 4 | 50 | 21 | 71 |
| 2023 3 | 69 | 46 | 115 |
| 2023 2 | 42 | 30 | 72 |
| 2023 1 | 51 | 28 | 79 |
| 2022 12 | 43 | 24 | 67 |
| 2022 11 | 59 | 55 | 114 |
| 2022 10 | 62 | 35 | 97 |
| 2022 9 | 34 | 70 | 104 |
| 2022 8 | 28 | 41 | 69 |
| 2022 7 | 35 | 44 | 79 |
| 2022 6 | 29 | 49 | 78 |
| 2022 5 | 24 | 40 | 64 |
| 2022 4 | 33 | 46 | 79 |
| 2022 3 | 26 | 58 | 84 |
| 2022 2 | 21 | 37 | 58 |
| 2022 1 | 31 | 49 | 80 |
| 2021 12 | 32 | 47 | 79 |
| 2021 11 | 38 | 50 | 88 |
| 2021 10 | 42 | 68 | 110 |
| 2021 9 | 20 | 39 | 59 |
| 2021 8 | 24 | 23 | 47 |
| 2021 7 | 24 | 25 | 49 |
| 2021 6 | 17 | 24 | 41 |
| 2021 5 | 17 | 31 | 48 |
| 2021 4 | 35 | 222 | 257 |
| 2021 3 | 18 | 22 | 40 |
| 2021 2 | 40 | 5 | 45 |
| 2021 1 | 19 | 3 | 22 |
| 2020 12 | 3 | 2 | 5 |
Show all
